Back to Search
ETHEL SIRIS, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1609943315IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
113079(NY)
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1971
Research & Publications (20)
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe.
PMID 19187810·Am J Med·2009
6-review
Effects of risedronate on fracture risk in postmenopausal women with osteopenia.
PMID 17968610·Osteoporos Int·2008
8-other
Enhanced prediction of fracture risk combining vertebral fracture status and BMD.
PMID 17245546·Osteoporos Int·2007
8-other
Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
PMID 17229018·J Bone Miner Res·2006
6-review
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
PMID 16392027·Osteoporos Int·2006
8-other
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
PMID 16901023·Mayo Clin Proc·2006
4-observational
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
PMID 16059623·J Bone Miner Res·2005
4-observational
Bone mineral density thresholds for pharmacological intervention to prevent fractures.
PMID 15159268·Arch Intern Med·2004
8-other
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
PMID 15231007·J Bone Miner Res·2004
8-other
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.
PMID 12915621·J Clin Endocrinol Metab·2003
6-review
Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation.
PMID 12415439·Osteoporos Int·2002
3-trial
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
PMID 11735756·JAMA·2001
8-other
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
PMID 19468663·Osteoporos Int·2009
4-observational
More on reports of esophageal cancer with oral bisphosphonate use.
PMID 19391259·N Engl J Med·2009
8-other
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA).
PMID 18797811·Osteoporos Int·2009
4-observational
Clinical issues with bisphosphonate therapy for osteoporosis. Introduction.
PMID 19187807·Am J Med·2009
8-other
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
PMID 19671655·N Engl J Med·2009
4-observational
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
PMID 18663402·Osteoporos Int·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 180 FORT WASHINGTON AVE
NEW YORK, NY 10032 - Phone
- (212) 305-6238
Quick Facts
- NPI
- 1609943315
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 55
- Publications
- 20
Are you this provider?
Claim Your Profile